[Politico] Wyden, Grassley want answers on Sovaldi
By: Brett Norman A bipartisan pair of senators is asking the pharmaceutical… Read More
By: Brett Norman A bipartisan pair of senators is asking the pharmaceutical… Read More
Gilead Sciences Inc. has been asked by two U.S. senators to explain how it… Read More
On Friday, July 11, AEI is hosting a session entitled “How will we pay for… Read More
The debate over the price of specialty drugs is intensifying and could well be… Read More
Costs to New Yorkers for One Drug Is 4 Times Entire Higher Education Spending… Read More
Sovaldi, the new drug to treat and cure Hepatitis C has certainly caused quite… Read More
A cure for hepatitis C is within reach for 170 million people around the world… Read More
Eyeing a $168-million annual price tag for two costly new hepatitis C drugs,… Read More
“More than 80 organizations are launching the Campaign for Sustainable Rx… Read More
“A broad coalition of health care groups is trying to compel the… Read More
“The outcry continues over the $1,000-a-pill hepatitis C drug made by… Read More
“The people who pay for drugs aren’t fully buying those arguments —… Read More